Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
1.050
-0.050 (-4.55%)
At close: Sep 18, 2024, 4:00 PM
1.070
+0.020 (1.90%)
After-hours: Sep 18, 2024, 7:42 PM EDT

Seres Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
0.37126.337.13144.9333.2234.51
Upgrade
Revenue Growth (YoY)
-99.71%1672.24%-95.08%336.33%-3.74%22.07%
Upgrade
Cost of Revenue
94.68145.86172.92141.8990.5780.14
Upgrade
Gross Profit
-94.3-19.54-165.793.04-57.36-45.64
Upgrade
Selling, General & Admin
68.7587.7479.6969.2630.7824.75
Upgrade
Other Operating Expenses
-5.180.71-1.73--
Upgrade
Operating Expenses
63.5788.4580.767.5330.7824.75
Upgrade
Operating Income
-157.87-107.98-246.49-64.49-88.13-70.38
Upgrade
Interest Expense
-16.15-13.18-6.02-2.91-2.92-0.5
Upgrade
Interest & Investment Income
7.427.33.062.870.951.03
Upgrade
Other Non Operating Income (Expenses)
4.5-0.1-0.02-0.551.430.89
Upgrade
EBT Excluding Unusual Items
-162.11-113.96-249.47-65.08-88.68-68.96
Upgrade
Merger & Restructuring Charges
------1.49
Upgrade
Gain (Loss) on Sale of Investments
-0.24-0.69-0.5-0.450.17
Upgrade
Pretax Income
-162.11-113.72-250.16-65.58-89.13-70.28
Upgrade
Net Income
-162.11-113.72-250.16-65.58-89.13-70.28
Upgrade
Net Income to Common
-162.11-113.72-250.16-65.58-89.13-70.28
Upgrade
Shares Outstanding (Basic)
139128108928057
Upgrade
Shares Outstanding (Diluted)
139128108928057
Upgrade
Shares Change (YoY)
10.89%18.44%17.86%14.93%40.85%39.04%
Upgrade
EPS (Basic)
-1.17-0.89-2.31-0.72-1.12-1.24
Upgrade
EPS (Diluted)
-1.17-0.89-2.31-0.72-1.12-1.24
Upgrade
Free Cash Flow
-184.64-125.33-238.64-2.88-94.2-77.52
Upgrade
Free Cash Flow Per Share
-1.33-0.98-2.21-0.03-1.18-1.37
Upgrade
Gross Margin
--15.46%-2.09%-172.68%-132.26%
Upgrade
Operating Margin
-42211.23%-85.48%-3458.05%-44.50%-265.33%-203.98%
Upgrade
Profit Margin
-43343.58%-90.02%-3509.50%-45.25%-268.33%-203.68%
Upgrade
Free Cash Flow Margin
-49367.91%-99.21%-3347.88%-1.99%-283.61%-224.67%
Upgrade
EBITDA
-151.58-101.74-239.86-58.55-81.55-62.78
Upgrade
EBITDA Margin
--80.54%--40.40%-245.53%-181.95%
Upgrade
D&A For EBITDA
6.36.246.635.956.587.6
Upgrade
EBIT
-157.87-107.98-246.49-64.49-88.13-70.38
Upgrade
EBIT Margin
--85.48%--44.50%-265.33%-203.98%
Upgrade
Revenue as Reported
0.37126.337.13144.9333.2234.51
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.